ID CTND1_MOUSE Reviewed; 938 AA. AC P30999; Q3TSU9; Q80XQ4; Q8CHF8; DT 01-JUL-1993, integrated into UniProtKB/Swiss-Prot. DT 15-JAN-2008, sequence version 2. DT 14-APR-2009, entry version 78. DE RecName: Full=Catenin delta-1; DE AltName: Full=p120 catenin; DE Short=p120(ctn); DE AltName: Full=Cadherin-associated Src substrate; DE Short=CAS; DE AltName: Full=p120(cas); GN Name=Ctnnd1; Synonyms=Catns, Kiaa0384; OS Mus musculus (Mouse). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; OC Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Sciurognathi; OC Muroidea; Muridae; Murinae; Mus. OX NCBI_TaxID=10090; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2). RC STRAIN=Swiss; RX MEDLINE=93096477; PubMed=1334250; RA Reynolds A.B., Herbert L., Cleveland J.L., Berg S.T., Gaut J.R.; RT "p120, a novel substrate of protein tyrosine kinase receptors and of RT p60v-src, is related to cadherin-binding factors beta-catenin, RT plakoglobin and armadillo."; RL Oncogene 7:2439-2445(1992). RN [2] RP SEQUENCE REVISION. RA Reynolds A.B.; RL Submitted (DEC-1992) to the EMBL/GenBank/DDBJ databases. RN [3] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3). RC TISSUE=Brain; RX MEDLINE=22353125; PubMed=12465718; DOI=10.1093/dnares/9.5.179; RA Okazaki N., Kikuno R., Ohara R., Inamoto S., Hara Y., Nagase T., RA Ohara O., Koga H.; RT "Prediction of the coding sequences of mouse homologues of KIAA gene: RT I. The complete nucleotide sequences of 100 mouse KIAA-homologous RT cDNAs identified by screening of terminal sequences of cDNA clones RT randomly sampled from size-fractionated libraries."; RL DNA Res. 9:179-188(2002). RN [4] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 3). RC STRAIN=C57BL/6J; TISSUE=Testis; RX PubMed=16141072; DOI=10.1126/science.1112014; RA Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N., RA Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K., RA Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M., RA Davis M.J., Wilming L.G., Aidinis V., Allen J.E., RA Ambesi-Impiombato A., Apweiler R., Aturaliya R.N., Bailey T.L., RA Bansal M., Baxter L., Beisel K.W., Bersano T., Bono H., Chalk A.M., RA Chiu K.P., Choudhary V., Christoffels A., Clutterbuck D.R., RA Crowe M.L., Dalla E., Dalrymple B.P., de Bono B., Della Gatta G., RA di Bernardo D., Down T., Engstrom P., Fagiolini M., Faulkner G., RA Fletcher C.F., Fukushima T., Furuno M., Futaki S., Gariboldi M., RA Georgii-Hemming P., Gingeras T.R., Gojobori T., Green R.E., RA Gustincich S., Harbers M., Hayashi Y., Hensch T.K., Hirokawa N., RA Hill D., Huminiecki L., Iacono M., Ikeo K., Iwama A., Ishikawa T., RA Jakt M., Kanapin A., Katoh M., Kawasawa Y., Kelso J., Kitamura H., RA Kitano H., Kollias G., Krishnan S.P., Kruger A., Kummerfeld S.K., RA Kurochkin I.V., Lareau L.F., Lazarevic D., Lipovich L., Liu J., RA Liuni S., McWilliam S., Madan Babu M., Madera M., Marchionni L., RA Matsuda H., Matsuzawa S., Miki H., Mignone F., Miyake S., Morris K., RA Mottagui-Tabar S., Mulder N., Nakano N., Nakauchi H., Ng P., RA Nilsson R., Nishiguchi S., Nishikawa S., Nori F., Ohara O., RA Okazaki Y., Orlando V., Pang K.C., Pavan W.J., Pavesi G., Pesole G., RA Petrovsky N., Piazza S., Reed J., Reid J.F., Ring B.Z., Ringwald M., RA Rost B., Ruan Y., Salzberg S.L., Sandelin A., Schneider C., RA Schoenbach C., Sekiguchi K., Semple C.A., Seno S., Sessa L., Sheng Y., RA Shibata Y., Shimada H., Shimada K., Silva D., Sinclair B., RA Sperling S., Stupka E., Sugiura K., Sultana R., Takenaka Y., Taki K., RA Tammoja K., Tan S.L., Tang S., Taylor M.S., Tegner J., Teichmann S.A., RA Ueda H.R., van Nimwegen E., Verardo R., Wei C.L., Yagi K., RA Yamanishi H., Zabarovsky E., Zhu S., Zimmer A., Hide W., Bult C., RA Grimmond S.M., Teasdale R.D., Liu E.T., Brusic V., Quackenbush J., RA Wahlestedt C., Mattick J.S., Hume D.A., Kai C., Sasaki D., Tomaru Y., RA Fukuda S., Kanamori-Katayama M., Suzuki M., Aoki J., Arakawa T., RA Iida J., Imamura K., Itoh M., Kato T., Kawaji H., Kawagashira N., RA Kawashima T., Kojima M., Kondo S., Konno H., Nakano K., Ninomiya N., RA Nishio T., Okada M., Plessy C., Shibata K., Shiraki T., Suzuki S., RA Tagami M., Waki K., Watahiki A., Okamura-Oho Y., Suzuki H., Kawai J., RA Hayashizaki Y.; RT "The transcriptional landscape of the mammalian genome."; RL Science 309:1559-1563(2005). RN [5] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1). RC STRAIN=C57BL/6; TISSUE=Brain; RX PubMed=15489334; DOI=10.1101/gr.2596504; RG The MGC Project Team; RT "The status, quality, and expansion of the NIH full-length cDNA RT project: the Mammalian Gene Collection (MGC)."; RL Genome Res. 14:2121-2127(2004). RN [6] RP INTERACTION WITH ZBTB33. RX MEDLINE=99223590; PubMed=10207085; RA Daniel J.M., Reynolds A.B.; RT "The catenin p120(ctn) interacts with Kaiso, a novel BTB/POZ domain RT zinc finger transcription factor."; RL Mol. Cell. Biol. 19:3614-3623(1999). RN [7] RP INTERACTION WITH ZBTB33. RX MEDLINE=22082336; PubMed=12087177; DOI=10.1093/nar/gkf398; RA Daniel J.M., Spring C.M., Crawford H.C., Reynolds A.B., Baig A.; RT "The p120(ctn)-binding partner Kaiso is a bi-modal DNA-binding protein RT that recognizes both a sequence-specific consensus and methylated CpG RT dinucleotides."; RL Nucleic Acids Res. 30:2911-2919(2002). RN [8] RP FUNCTION, NUCLEAR LOCALIZATION SIGNAL, SUBCELLULAR LOCATION, AND RP MUTAGENESIS OF 622-LYS-LYS-623. RX PubMed=15138284; DOI=10.1242/jcs.01101; RA Kelly K.F., Spring C.M., Otchere A.A., Daniel J.M.; RT "NLS-dependent nuclear localization of p120ctn is necessary to relieve RT Kaiso-mediated transcriptional repression."; RL J. Cell Sci. 117:2675-2686(2004). RN [9] RP ERRATUM. RA Kelly K.F., Spring C.M., Otchere A.A., Daniel J.M.; RL J. Cell Sci. 117:3405-3405(2004). RN [10] RP FUNCTION. RX PubMed=15817151; DOI=10.1016/j.yexcr.2005.01.007; RA Spring C.M., Kelly K.F., O'Kelly I., Graham M., Crawford H.C., RA Daniel J.M.; RT "The catenin p120ctn inhibits Kaiso-mediated transcriptional RT repression of the beta-catenin/TCF target gene matrilysin."; RL Exp. Cell Res. 305:253-265(2005). RN [11] RP PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-904, AND MASS RP SPECTROMETRY. RC TISSUE=Mast cell; RX PubMed=17947660; RA Cao L., Yu K., Banh C., Nguyen V., Ritz A., Raphael B.J., Kawakami Y., RA Kawakami T., Salomon A.R.; RT "Quantitative time-resolved phosphoproteomic analysis of mast cell RT signaling."; RL J. Immunol. 179:5864-5876(2007). RN [12] RP INTERACTION WITH GLIS2, FUNCTION, AND SUBCELLULAR LOCATION. RX PubMed=17344476; DOI=10.1091/mbc.E06-10-0941; RA Hosking C.R., Ulloa F., Hogan C., Ferber E.C., Figueroa A., RA Gevaert K., Birchmeier W., Briscoe J., Fujita Y.; RT "The transcriptional repressor Glis2 is a novel binding partner for RT p120 catenin."; RL Mol. Biol. Cell 18:1918-1927(2007). RN [13] RP PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-349, AND MASS RP SPECTROMETRY. RC TISSUE=Brain cortex; RX PubMed=17114649; DOI=10.1074/mcp.M600046-MCP200; RA Munton R.P., Tweedie-Cullen R., Livingstone-Zatchej M., Weinandy F., RA Waidelich M., Longo D., Gehrig P., Potthast F., Rutishauser D., RA Gerrits B., Panse C., Schlapbach R., Mansuy I.M.; RT "Qualitative and quantitative analyses of protein phosphorylation in RT naive and stimulated mouse synaptosomal preparations."; RL Mol. Cell. Proteomics 6:283-293(2007). RN [14] RP PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-288; TYR-291; SER-320; RP SER-349; SER-352; SER-859 AND TYR-865, AND MASS SPECTROMETRY. RC TISSUE=Liver; RX PubMed=17242355; DOI=10.1073/pnas.0609836104; RA Villen J., Beausoleil S.A., Gerber S.A., Gygi S.P.; RT "Large-scale phosphorylation analysis of mouse liver."; RL Proc. Natl. Acad. Sci. U.S.A. 104:1488-1493(2007). RN [15] RP PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-217; TYR-228; TYR-257 RP AND TYR-280, AND MASS SPECTROMETRY. RX PubMed=17389395; DOI=10.1073/pnas.0608638104; RA Wolf-Yadlin A., Hautaniemi S., Lauffenburger D.A., White F.M.; RT "Multiple reaction monitoring for robust quantitative proteomic RT analysis of cellular signaling networks."; RL Proc. Natl. Acad. Sci. U.S.A. 104:5860-5865(2007). RN [16] RP PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-349, AND MASS RP SPECTROMETRY. RC TISSUE=Liver; RX PubMed=18630941; DOI=10.1021/pr800223m; RA Zhou H., Ye M., Dong J., Han G., Jiang X., Wu R., Zou H.; RT "Specific phosphopeptide enrichment with immobilized titanium ion RT affinity chromatography adsorbent for phosphoproteome analysis."; RL J. Proteome Res. 7:3957-3967(2008). CC -!- FUNCTION: May associate with and regulate the cell adhesion CC properties of both C- and E-cadherins. Implicated both in cell CC transformation by SRC and in ligand-induced receptor signaling CC through the EGF, PDGF, CSF-1 and ERBB2 receptors (By similarity). CC Binds to and inhibits the transcriptional repressor ZBTB33, which CC may lead to activation of target genes of the Wnt signaling CC pathway. Promotes GLIS2 C-terminal cleavage. CC -!- SUBUNIT: Belongs to a multiprotein cell-cell adhesion complex that CC also contains E-cadherin, alpha-catenin, beta-catenin, and gamma- CC catenin. Binds to the C-terminal fragment of PSEN1 and mutually CC competes for E-cadherin (By similarity). Interacts with ZBTB33. CC Interacts with GLIS2. CC -!- SUBCELLULAR LOCATION: Cytoplasm. Nucleus. Cell membrane. CC Note=Interaction with GLIS2 promotes nuclear translocation. CC -!- ALTERNATIVE PRODUCTS: CC Event=Alternative splicing; Named isoforms=3; CC Name=1; CC IsoId=P30999-1; Sequence=Displayed; CC Name=2; CC IsoId=P30999-2; Sequence=VSP_030567, VSP_030568; CC Name=3; CC IsoId=P30999-3; Sequence=VSP_030568; CC -!- PTM: Phosphorylated by protein-tyrosine kinases. CC -!- SIMILARITY: Belongs to the beta-catenin family. CC -!- SIMILARITY: Contains 10 ARM repeats. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; Z17804; CAA79078.1; -; mRNA. DR EMBL; AB093237; BAC41421.1; ALT_INIT; mRNA. DR EMBL; AK133193; BAE21551.1; -; mRNA. DR EMBL; AK161790; BAE36576.1; -; mRNA. DR EMBL; BC043108; AAH43108.1; -; mRNA. DR EMBL; BC054544; AAH54544.1; -; mRNA. DR IPI; IPI00316623; -. DR IPI; IPI00403823; -. DR IPI; IPI00660602; -. DR PIR; I48701; S28498. DR RefSeq; NP_001078917.1; -. DR RefSeq; NP_001078918.1; -. DR RefSeq; NP_001078919.1; -. DR RefSeq; NP_001078922.1; -. DR RefSeq; NP_031641.2; -. DR UniGene; Mm.35738; -. DR IntAct; P30999; 3. DR PhosphoSite; P30999; -. DR PRIDE; P30999; -. DR Ensembl; ENSMUSG00000034101; Mus musculus. DR GeneID; 12388; -. DR KEGG; mmu:12388; -. DR MGI; MGI:105100; Ctnnd1. DR HOVERGEN; P30999; -. DR NextBio; 281110; -. DR ArrayExpress; P30999; -. DR Bgee; P30999; -. DR CleanEx; MM_CTNND1; -. DR GermOnline; ENSMUSG00000034101; Mus musculus. DR GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-KW. DR GO; GO:0030027; C:lamellipodium; IDA:MGI. DR GO; GO:0005624; C:membrane fraction; IDA:MGI. DR GO; GO:0005634; C:nucleus; IEA:UniProtKB-KW. DR GO; GO:0005886; C:plasma membrane; IEA:UniProtKB-KW. DR GO; GO:0019903; F:protein phosphatase binding; IPI:UniProtKB. DR GO; GO:0042153; F:RPTP-like protein binding; IPI:MGI. DR GO; GO:0007155; P:cell adhesion; IMP:MGI. DR GO; GO:0006355; P:regulation of transcription, DNA-dependent; IEA:UniProtKB-KW. DR GO; GO:0016055; P:Wnt receptor signaling pathway; IEA:UniProtKB-KW. DR InterPro; IPR000225; Armadillo. DR Pfam; PF00514; Arm; 4. DR SMART; SM00185; ARM; 6. DR PROSITE; PS50176; ARM_REPEAT; 3. PE 1: Evidence at protein level; KW Alternative splicing; Cell adhesion; Cell membrane; Coiled coil; KW Cytoplasm; Membrane; Nucleus; Phosphoprotein; Repeat; Transcription; KW Transcription regulation; Wnt signaling pathway. FT CHAIN 1 938 Catenin delta-1. FT /FTId=PRO_0000064297. FT REPEAT 358 395 ARM 1. FT REPEAT 398 437 ARM 2. FT REPEAT 441 475 ARM 3. FT REPEAT 476 516 ARM 4. FT REPEAT 534 573 ARM 5. FT REPEAT 583 624 ARM 6. FT REPEAT 653 693 ARM 7. FT REPEAT 700 739 ARM 8. FT REPEAT 740 780 ARM 9. FT REPEAT 781 826 ARM 10. FT COILED 10 46 Potential. FT MOTIF 622 635 Nuclear localization signal. FT MOD_RES 47 47 Phosphoserine (By similarity). FT MOD_RES 96 96 Phosphotyrosine (By similarity). FT MOD_RES 174 174 Phosphotyrosine (By similarity). FT MOD_RES 217 217 Phosphotyrosine. FT MOD_RES 228 228 Phosphotyrosine. FT MOD_RES 230 230 Phosphoserine (By similarity). FT MOD_RES 232 232 Phosphoserine (By similarity). FT MOD_RES 244 244 Phosphoserine (By similarity). FT MOD_RES 257 257 Phosphotyrosine. FT MOD_RES 268 268 Phosphoserine (By similarity). FT MOD_RES 269 269 Phosphoserine (By similarity). FT MOD_RES 280 280 Phosphotyrosine. FT MOD_RES 288 288 Phosphoserine. FT MOD_RES 291 291 Phosphotyrosine. FT MOD_RES 302 302 Phosphotyrosine (By similarity). FT MOD_RES 310 310 Phosphothreonine (By similarity). FT MOD_RES 320 320 Phosphoserine. FT MOD_RES 321 321 Phosphotyrosine (By similarity). FT MOD_RES 334 334 Phosphotyrosine (By similarity). FT MOD_RES 349 349 Phosphoserine. FT MOD_RES 352 352 Phosphoserine. FT MOD_RES 859 859 Phosphoserine. FT MOD_RES 865 865 Phosphotyrosine. FT MOD_RES 869 869 Phosphothreonine (By similarity). FT MOD_RES 904 904 Phosphotyrosine. FT MOD_RES 916 916 Phosphothreonine (By similarity). FT VAR_SEQ 626 631 Missing (in isoform 2). FT /FTId=VSP_030567. FT VAR_SEQ 880 900 Missing (in isoform 2 and isoform 3). FT /FTId=VSP_030568. FT MUTAGEN 622 623 KK->AA: Abolishes nuclear localization. FT CONFLICT 405 405 R -> A (in Ref. 1; CAA79078). FT CONFLICT 676 676 K -> N (in Ref. 1; CAA79078). FT CONFLICT 715 715 I -> R (in Ref. 1; CAA79078). FT CONFLICT 752 752 I -> R (in Ref. 1; CAA79078). SQ SEQUENCE 938 AA; 104925 MW; 2F13DB7350355832 CRC64; MDDSEVESTA SILASVKEQE AQFEKLTRAL EEERRHVSAQ LERVRVSPQD ANSLMANGTL TRRHQNGRFV GDADLERQKF SDLKLNGPQD HNHLLYSTIP RMQEPGQIVE TYTEEDPEGA MSVVSVETTD DGTTRRTETT VKKVVKTMTT RTVQPVPMGP DGLPVDASAV SNNYIQTLGR DFRKNGNGGP GPYVGQAGTA TLPRNFHYPP DGYGRHYEDG YPGGSDNYGS LSRVTRIEER YRPSMEGYRA PSRQDVYGPQ PQVRVGGSSV DLHRFHPEPY GLEDDQRSMG YDDLDYGMMS DYGTARRTGT PSDPRRRLRS YEDMIGEEVP PDQYYWAPLA QHERGSLASL DSLRKGMPPP SNWRQPELPE VIAMLGFRLD AVKSNAAAYL QHLCYRNDKV KTDVRKLKGI PILVGLLDHP KKEVHLGACG ALKNISFGRD QDNKIAIKNC DGVPALVRLL RKARDMDLTE VITGTLWNLS SHDSIKMEIV DHALHALTDE VIIPHSGWER EPNEDCKPRH IEWESVLTNT AGCLRNVSSE RSEARRKLRE CDGLVDALIF IVQAEIGQKD SDSKLVENCV CLLRNLSYQV HREIPQAERY QEALPTVANS TGPHAASCFG AKKGKDEWFS RGKKPTEDPA NDTVDFPKRT SPARGYELLF QPEVVRIYIS LLKESKTPAI LEASAGAIQN LCAGRWTYGR YIRSALRQEK ALSAIAELLT SEHERVVKAA SGALRNLAVD ARNKELIGKH AIPNLVKNLP GGQQNSSWNF SEDTVVSILN TINEVIAENL EAAKKLRETQ GIEKLVLINK SGNRSEKEVR AAALVLQTIW GYKELRKPLE KEGWKKSDFQ VNLNNASRSQ SSHSYDDSTL PLIDRNQKSD KKPDREEIPM SNMGSNTKSL DNNYSTLNER GDHNRTLDRS GDLGDMEPLK GAPLMQKI //